Overview

To Evaluate the Safety, Tolerability and Efficacy of R2R01 Combined With SOC as Compared to SOC Alone in Outpatients With Worsening Heart Failure (WHF)

Status:
COMPLETED

Trial end date:
2024-11-25

Target enrollment:

Participant gender:

Summary

This Study Aims to Evaluate the Safety, Tolerability and Efficacy of R2R01 Combined With SOC as Compared to SOC Alone in Outpatients With Worsening Heart Failure (WHF)

Phase:

PHASE2

Details

Lead Sponsor:

River 2 Renal Corp.

Collaborator:

International HealthCare, LLC